NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: Shareholders provide further support for Rett syndrome, page-25

  1. 2,756 Posts.
    lightbulb Created with Sketch. 383
    This CR is very bullish.

    CR at a premium! Placement at $0.09, last close $0.089. Quite rare.
    LW averaged down! Thanks to WhatAG for that important reminder.
    LW, as NEU's biggest shareholder, would have a few key phone numbers... and they would TAKE the call.
    High conviction BUY. High confidence for a profit. Very long term holder

    As for, "Work it out smartie[.]" s64, Stunning as it may seem, NEU does NOT have a crystal ball. Considering, "a bird in the hand..." To reiterate, this move at a premium to sp is prudent, provides confidence, perhaps a floor price, and gives those on the sidelines quite a bit to ponder, eg. news timeline. However, with a working crystal ball NEU should've asked for $0.45!

    Pure Speculation: Have we just witnessed the beginning of a climb to thhe mid-high teens, before news?

    OV
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.59
Change
0.380(2.50%)
Mkt cap ! $1.992B
Open High Low Value Volume
$15.51 $15.82 $15.46 $11.26M 722.0K

Buyers (Bids)

No. Vol. Price($)
1 696 $15.59
 

Sellers (Offers)

Price($) Vol. No.
$15.67 6942 8
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.